,trastuzumab deruxtecan
daiichi sankyo,astrazeneca
[]
the applause for the db-04 trial at the #asco22 plenary session speaks for its impressive results!! look at these curves! 
Hematology and Medical Oncology fellow at Duke University, Lebanese, husband to the best anesthesiologist, IO fan, trialist and skin cancer specialist to be!